|
NOTE 3 — REVENUES
Revenues disaggregated by category were as follows (in thousands):
|
|
|
For the three months ended June 30,
|
|
|
For the six months ended June 30,
|
|
|
|
|
2019
|
|
|
2018
|
|
|
2019
|
|
|
2018
|
|
|
Endari®
|
|
$
|
5,764
|
|
|
$
|
2,370
|
|
|
$
|
10,966
|
|
|
$
|
3,060
|
|
|
Other
|
|
|
105
|
|
|
|
201
|
|
|
|
210
|
|
|
|
292
|
|
|
Revenues, net
|
|
|
5,869
|
|
|
|
2,571
|
|
|
|
11,176
|
|
|
|
3,352
|
|
The following table summarizes the revenue allowance and accrual activities for the six months ended June 30, 2019 (in thousands):
|
|
|
Trade Discounts, Allowances and Chargebacks
|
|
|
Government Rebates and Other Incentives
|
|
|
Returns
|
|
|
Total
|
|
|
Balance as of December 31, 2018
|
|
$
|
303
|
|
|
$
|
1,880
|
|
|
$
|
181
|
|
|
$
|
2,363
|
|
|
Provision related to sales in the current year
|
|
|
649
|
|
|
|
1,625
|
|
|
|
121
|
|
|
|
2,395
|
|
|
Adjustments related prior period sales
|
|
|
—
|
|
|
|
(976
|
)
|
|
|
—
|
|
|
|
(976
|
)
|
|
Credit and payments made
|
|
|
(614
|
)
|
|
|
(1,157
|
)
|
|
|
—
|
|
|
|
(1,771
|
)
|
|
Balance as of June 30, 2019
|
|
$
|
338
|
|
|
$
|
1,372
|
|
|
$
|
302
|
|
|
$
|
2,011
|
|
The following table summarizes revenues attributable to each of our customers who accounted for 10% or more of our total revenues (as a percentage of total revenues):
|
|
|
For the three months ended June 30,
|
|
|
For the six months ended June 30,
|
|
|
|
|
2019
|
|
|
2018
|
|
|
2019
|
|
|
2018
|
|
|
AmerisourceBergen Specialty Group
|
|
|
61
|
%
|
|
|
89
|
%
|
|
|
61
|
%
|
|
|
88
|
%
|
|
McKesson Plasma and Biologics LLC
|
|
|
23
|
%
|
|
|
—
|
|
|
|
20
|
%
|
|
|
—
|
|
|